Pro-Life Scholars Sue After ‘Discriminatory’ Retractions by Academic Journal

Dr. James Studnicki

Pro-life scholars and Sage Publications continue to battle over retracted articles.

Dr. James Studnicki and his fellow authors sued Sage Publications to compel arbitration after the publishing company retracted three articles for allegedly “pretextual and discriminatory reasons,” according to the legal filing.

Read More

GOP Lawmakers Take Aim at College Campuses Distributing Abortion Drugs

Republican lawmakers are introducing pro-life legislation aimed at protecting babies with Down syndrome and stopping college campuses from distributing abortion pills to students. Introduced by Republican Texas Rep. Chip Roy in the House and Republican Montana Sen. Steve Daines in the Senate, the Protecting Life on College Campus Act of 2023 would prohibit “the award of federal funds to an institution of higher education that hosts or is affiliated with a student-based service site that provides abortion drugs or abortions” to students or university employees.

Read More

Commentary: Planned Parenthood Directs Women to Illegal Abortions

Planned Parenthood is directing its patients to a service that guides women through the process of illegally importing abortion drugs into the United States. The information is communicated prominently on a landing page that links from the front page of the organization’s website. It’s all part of a broader plan by abortion activists to use the illegal trade of drugs like mifepristone and misoprostol to provide abortions in states where abortion will be banned if Roe v. Wade is overturned.

Read More

Pro-Life Groups Accuse FDA of ‘Ignoring the Science’ on at-Home Abortion Drugs

Pro-life groups are accusing the Food and Drug Administration of “ignoring the science” by removing restrictions that prevented abortion drugs from being delivered by mail.

The national pro-life Susan B. Anthony List (SBA List) and its research and education arm, the Charlotte Lozier Institute (CLI), said Tuesday that the FDA’s decision to remove restrictions on abortion drugs “ignores the risk of increased mortality and morbidity for women taking the abortion pill,” according to an SBA List press release.

Read More